MARKET

UROV

UROV

Urovant Sciences
NASDAQ

Real-time Quotes | Nasdaq Last Sale

12.02
-0.40
-3.22%
Closed 16:00 02/27 EST
OPEN
12.35
PREV CLOSE
12.42
HIGH
12.53
LOW
10.91
VOLUME
76.84K
TURNOVER
--
52 WEEK HIGH
15.98
52 WEEK LOW
6.45
MARKET CAP
360.90M
P/E (TTM)
-2.9301
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of UROV and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average UROV stock price target is 25.25 with a high estimate of 33.00 and a low estimate of 19.00.

EPS

UROV News

More
  • Urovant Sciences to Present at Cowen and Company’s 40th Annual Health Care Conference
  • Business Wire · 2d ago
  • Urovant Sciences' (UROV) CEO Keith Katkin on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 02/14 02:31
  • Urovant Sciences Q3 EPS $(1.36) Misses $(0.98) Estimate
  • Benzinga · 02/13 21:23
  • Urovant Sciences Reports 2019 Third Fiscal Quarter Financial Results
  • Business Wire · 02/13 21:15

Industry

Biotechnology & Medical Research
-2.24%
Pharmaceuticals & Medical Research
-2.52%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About UROV

Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for urologic conditions. Its product candidate, vibegron, is an oral, once-daily, small molecule beta-3 agonist. is focused on evaluating vibegron in its over 1,400 patients, pivotal phase-3 clinical trial for the treatment of overactive bladder (OAB). The Company’s subsidiaries include Urovant Sciences, Inc., Urovant Holdings Limited, and Urovant Sciences GmbH.
More

Webull offers kinds of Urovant Sciences Ltd stock information, including NASDAQ:UROV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UROV stock news, and many more online research tools to help you make informed decisions.